Ramalin-Mediated Apoptosis Is Enhanced by Autophagy Inhibition in Human Breast Cancer Cells

Phytotherapy Research

Volumn 30, Issue 3, 2016, Pages 426-438

  Lee, Eunyoung ^a   Lee, Chung Gi ^a   Yim, Joung Han ^b   Lee, Hong Kum ^b   Pyo, Suhkneung ^a  

^a Sungkyunkwan University   (South Korea)

^b Korea Research Institute of Ships and Ocean Engineering   (South Korea)

Author keywords

apoptosis; autophagy; breast cancer cells; ramalin

Indexed keywords

3 METHYLADENINE; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; PROTEIN BCL 2; PROTEIN P62; RAMALIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; 3-METHYLADENINE; ADENINE; ANTIOXIDANT; APOPTOSIS INDUCING FACTOR; ATG5 PROTEIN, HUMAN; AUTOPHAGY RELATED PROTEIN 5; BAX PROTEIN, HUMAN; BCL2 PROTEIN, HUMAN; BIOLOGICAL PRODUCT; CASPASE; GLUTAMIC ACID DERIVATIVE; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN BAX;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; AUTOPHAGY INHIBITION; BREAST CANCER; BREAST CANCER CELL LINE; CANCER CELL DESTRUCTION; CONTROLLED STUDY; CYTOSOL; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; HUMAN CELL; MITOCHONDRION; ANALOGS AND DERIVATIVES; BREAST NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; FEMALE; LICHEN (ORGANISM); METABOLISM;

ADENINE; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; APOPTOSIS INDUCING FACTOR; AUTOPHAGY; AUTOPHAGY-RELATED PROTEIN 5; BCL-2-ASSOCIATED X PROTEIN; BIOLOGICAL PRODUCTS; BREAST NEOPLASMS; CASPASES; CELL CYCLE; CELL PROLIFERATION; CYTOCHROMES C; FEMALE; GLUTAMATES; HUMANS; LICHENS; MICROTUBULE-ASSOCIATED PROTEINS; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84959544923     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5544     Document Type: Article

References (45)

1. Badve S, Nakshatri H,. 2009. Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications. J Clin Pathol 62: 6-12.
2. Burlacu A,. 2003. Regulation of apoptosis by Bcl-2 family proteins. J Cell Mol Med 7: 249-257.
3. Chipuk JE, Green DR,. 2008. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 18: 157-164.
4. Chou C, Yang J, Lu H, et al., 2010. Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade through the mitochondrial pathway in human breast cancer MCF-7 cells. Arch Pharm Res 33: 1181-1191.
5. Du C, Fang M, Li Y, Li L, Wang X,. 2000. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102: 33-42.
6. Duffy MJ,. 2006. Estrogen receptors: role in breast cancer. Crit Rev Clin Lab Sci 43: 325-347.
7. Eisenberg-Lerner A, Bialik S, Simon H, Kimchi A,. 2009. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ 16: 966-975.
8. Elmore S,. 2007. Apoptosis: a review of programmed cell death. Toxicol Pathol 35: 495-516.
9. Finucane DM, Bossy-Wetzel E, Waterhouse NJ, Cotter TG, Green DR,. 1999. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J Biol Chem 274: 2225-2233.
10. Gozuacik D, Kimchi A,. 2004. Autophagy as a cell death and tumour suppressor mechanism. Oncogene 23: 2891-2906.
11. Hanahan D, Weinberg RA,. 2000. The hallmarks of cancer. Cell 100: 57-70.
12. Haupt S, Berger M, Goldberg Z, Haupt Y,. 2003. Apoptosis-the p53 network. J Cell Sci 116: 4077-4085.
13. Hemann M, Lowe S,. 2006. The p53-Bcl-2 connection. Cell Death Differ 13: 1256-1259.
14. Herzog C, Yang C, Holmes A, Kaushal GP,. 2012. zVAD-fmk prevents cisplatin-induced cleavage of autophagy proteins but impairs autophagic flux and worsens renal function. Am J Physiol Renal Physiol 303: F1239-F1250.
15. Hulka BS, Moorman PG,. 2001. Breast cancer: hormones and other risk factors. Maturitas 38: 103-113.
16. Huneck S,. 1999. The significance of lichens and their metabolites. Naturwissenschaften 86: 559-570.
17. Jain K, Paranandi KS, Sridharan S, Basu A,. 2013. Autophagy in breast cancer and its implications for therapy. Am J Cancer Res 3: 251-256.
18. Jang M, Park BC, Lee AY, et al., 2007. Caspase-7 mediated cleavage of proteasome subunits during apoptosis. Biochem Biophys Res Commun 363: 388-394.
19. Janicke RU, Ng P, Sprengart ML, Porter AG,. 1998. Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J Biol Chem 273: 15540-15545.
20. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. 2011. Global cancer statistics. CA Cancer J Clin 61: 69-90.
21. Jensen EV, Jordan VC,. 2003. The oestrogen receptor: a model for molecular medicine. Clin Cancer Res 9: 1980-1989.
22. Jin S, White E,. 2007. Role of autophagy in cancer: management of metabolic stress. Autophagy 3: 28-31.
23. Jin S, Zhang QY, Kang XM, Wang JX, Zhao WH,. 2010. Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway. Ann Oncol 21: 263-268.
24. Jordan VC, O'Malley BW,. 2007. Selective estrogen-receptor modulators and antihormonal resistance in breast cancer. J Clin Oncol 25: 5815-5824.
25. Kanematsu S, Uehara N, Miki H, et al., 2010. Autophagy inhibition enhances sulforaphane-induced apoptosis in human breast cancer cells. Anticancer Res 30: 3381-3390.
26. Kaushal GP,. 2012. Autophagy protects proximal tubular cells from injury and apoptosis. Kidney Int 82: 1250-1253.
27. Lavrik I, Golks A, Krammer PH,. 2005. Death receptor signaling. J Cell Sci 118: 265-267.
28. Lee J, Kim J, Rhee D, Pyo S,. 2013. Streptococcus pneumoniae ClpP protease induces apoptosis via caspase-independent pathway in human neuroblastoma cells: cytoplasmic relocalization of p53. Toxicon 70: 142-152.
29. Morelli C, Garofalo C, Bartucci M, Surmacz E,. 2003. Estrogen receptor-α regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells. Oncogene 22: 4007-4016.
30. Müller K,. 2001. Pharmaceutically relevant metabolites from lichens. Appl Microbiol Biotechnol 56: 9-16.
31. Nguyen CT, Luong TT, Kim GL, Pyo S, Rhee DK,. 2015. Korean Red Ginseng inhibits apoptosis in neuroblastoma cells via estrogen receptor beta-mediated phosphatidylinositol-3 kinase/Akt signaling. J Ginseng Res 39: 69-75.
32. Nicholson DW,. 2000. From bench to clinic with apoptosis-based therapeutic agents. Nature 407: 810-816.
33. Paudel B, Bhattarai HD, Koh HY, et al., 2011. Ramalin, a novel nontoxic antioxidant compound from the Antarctic lichen Ramalina terebrata. Phytomedicine 18: 1285-1290.
34. Puissant A, Robert G, Fenouille N, et al., 2010. Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation. Cancer Res 70: 1042-1052.
35. Puissant A, Fenouille N, Auberger P,. 2012. When autophagy meets cancer through p62/SQSTM1. Cancer Res 2: 397-413.
36. Robert G, Sahra IB, Puissant A, et al., 2009. Acadesine kills chronic myelogenous leukemia (CML) cells through PKC-dependent induction of autophagic cell death. PLoS One 4 e7889.
37. Rouzier R, Perou CM, Symmans WF, et al., 2005. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 11: 5678-5685.
38. Scata KA, El-Deiry WS,. 2007. p53, BRCA1 and breast cancer chemoresistance. Adv Exp Med Biol 608: 70-86.
39. Shen K, Rice SD, Gingrich DA, et al., 2012. Distinct genes related to drug response identified in ER positive and ER negative breast cancer cell lines. PLoS One 7 e40900:.
40. Suyama K, Noguchi Y, Tanaka T, et al., 2007. Isoprenoid-independent pathway is involved in apoptosis induced by risedronate, a bisphosphonate, in which Bim plays a critical role in breast cancer cell line MCF-7. Oncol Rep 18: 1291-1298.
41. Tait SW, Green DR,. 2010. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11: 621-632.
42. Tsao CH, Su HL, Lin YL, et al., 2008. Japanese encephalitis virus infection activates caspase-8 and -9 in a FADD-independent and mitochondrion-dependent manner. J Gen Virol 89: 1930-1941.
43. Wong CH, Iskandar KB, Yadav SK, Hirpara JL, Loh T, Pervaiz S,. 2010. Simultaneous induction of non-canonical autophagy and apoptosis in cancer cells by ROS-dependent ERK and JNK activation. PLoS One 5 e9996:.
44. Yang PM, Tseng HH, Peng CW, Chen WS, Chiu SJ,. 2012. Dietary flavonoid fisetin targets caspase-3-deficient human breast cancer MCF-7 cells by induction of caspase-7-associated apoptosis and inhibition of autophagy. Int J Oncol 40: 469-478.
45. Yoshimori T,. 2004. Autophagy: a regulated bulk degradation process inside cells. Biochem Biophys Res Commun 313: 453-458.